Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
- Substances:PembrolizumabResiquimod Sulfate
Hungary- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Pembrolizumab
Rare diseases
Investigational molecules
Locations
HungaryStudy of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response
HungaryStudy on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)
HungaryStudy on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration
HungaryStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
HungaryStudy on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
HungaryStudy on the Safety and Tolerability of Treprostinil Sodium for Children with Pulmonary Arterial Hypertension
HungaryStudy on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation
HungaryStudy on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer's Disease
HungaryStudy on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause
HungaryStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments
HungaryLong-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.